Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 45.77B P/E 35.67 EPS this Y -12.40% Ern Qtrly Grth -36.90%
Income 1.49B Forward P/E 18.97 EPS next Y 8.80% 50D Avg Chg -6.00%
Sales 15.49B PEG 12.23 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 2.26 EPS next 5Y 1.49% 52W High Chg -14.00%
Recommedations 2.50 Quick Ratio 0.54 Shares Outstanding 1.91B 52W Low Chg 6.00%
Insider Own 0.02% ROA 5.91% Shares Float 1.73B Beta -
Inst Own 99.67% ROE 9.65% Shares Shorted/Prior 27.80M/34.60M Price 23.90
Gross Margin 56.57% Profit Margin 9.63% Avg. Volume 6,846,304 Target Price 22.40
Oper. Margin 17.00% Earnings Date - Volume 15,999,131 Change 1.06%
About Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc. News
05/14/24 Kenvue Announces Pricing of Secondary Offering
05/13/24 CPI expectations, GameStop stock, EV slowdown: Catalysts
05/13/24 Johnson & Johnson to sell remaining stake in Kenvue
05/13/24 Kenvue Announces Launch of Secondary Offering
05/08/24 Kenvue First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
05/08/24 Kenvue Inc (KVUE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Operational ...
05/07/24 Kenvue (KVUE) Q1 2024 Earnings Call Transcript
05/07/24 Oscar Health, Kenvue, Hims & Hers: Health earnings roundup
05/07/24 Kenvue Reports First Quarter 2024 Results
05/02/24 Kenvue Advances Its Healthy Lives Mission and Climate Action Commitment With Science-Based Targets Validation
04/27/24 7 Stocks to Buy if Inflation Continues to Reign in 2024
04/25/24 Kenvue Declares Quarterly Cash Dividend
04/24/24 Will Weakness in Kenvue Inc.'s (NYSE:KVUE) Stock Prove Temporary Given Strong Fundamentals?
04/16/24 J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business
04/08/24 Kenvue Revamps Cyber Tools After Spinoff From J&J
04/05/24 Kenvue to Announce First Quarter 2024 Results on May 7, 2024
03/12/24 7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability
03/07/24 Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
03/05/24 Heard on the Street: Does Bayer Have the Formula to Avoid a Breakup?
02/13/24 Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
KVUE Chatroom

User Image JonETrades Posted - 3 days ago

$KVUE 21C 06/07 $94k

User Image ProTraderColin Posted - 3 days ago

$KVUE nice red to green recovery from the premarket

User Image Stocksrunner Posted - 3 days ago

📈 Unusual Volume Detected! 🚀 $KVUE: Kenvue experiences high trading activity as it prices secondary stock offering with Johnson & Johnson exiting. Stay tuned for insights into the potential reasons driving this increased activity. https://stocksrunner.com/symbol/KVUE

User Image Jebus29 Posted - 4 days ago

$KVUE

User Image OpenOutcrier Posted - 4 days ago

$KVUE (-2.1% pre) Kenvue (KVUE) Prices 182.33M Share Secondary Offering at $20/sh - SI https://ooc.bz/l/33073

User Image basscat12 Posted - 4 days ago

$PSEC $AKAM $KVUE $TTOO Morning Mash U, page 3, Insider Purchas/ Syndicate/filings presented here for @Vegas1 to help prepare for today's opportunities!

User Image DonCorleone77 Posted - 4 days ago

$KVUE Kenvue 182.33M share Secondary priced at $20.00 The deal priced below last closing price of $20.63. Goldman Sachs, JPMorgan and BofA are acting as joint book running managers for the offering.

User Image Stock_Titan Posted - 4 days ago

$KVUE $JNJ Kenvue Announces Pricing of Secondary Offering https://www.stocktitan.net/news/KVUE/kenvue-announces-pricing-of-secondary-9zzshqa0a7js.html

User Image OptionRunners Posted - 4 days ago

$KVUE calls are almost $0.50 now

User Image ProTraderColin Posted - 4 days ago

$KVUE really strong grinder. Going for big 22 level breakout.

User Image Richk515 Posted - 5 days ago

$KVUE anyone else adding to their portfolio? This is definitely a contrarian play

User Image JonETrades Posted - 5 days ago

$KVUE 20.5C 05/24 $71k

User Image InvestorPlace Posted - 5 days ago

$JNJ is selling its stake in $KVUE! https://investorplace.com/2024/05/johnson-johnson-is-officially-getting-out-of-kenvue-kvue-stock/

User Image OpenOutcrier Posted - 6 days ago

$KVUE (-0.7% pre) $JNJ J&J to exit Kenvue, a year after spinoff - Reuters https://ooc.bz/l/32857

User Image DonCorleone77 Posted - 6 days ago

$KVUE $JNJ Kenvue confirms launch of 182.33M secondary offering for holders Kenvue (KVUE) announced the launch of a secondary underwritten public offering of 182,329,550 shares of its common stock. Kenvue is not selling any shares of common stock and will not receive any proceeds from the sale of the Shares in the Offering or from the debt-for-equity exchange. In connection with the Offering, Johnson & Johnson (JNJ) is expected to exchange 182,329,550 shares of Kenvue's common stock for indebtedness of Johnson & Johnson expected to be held by Goldman Sachs & Co. LLC and J.P. Morgan. Following the debt-for-equity exchange, if consummated, the Selling Shareholders intend to sell the Shares to the underwriters in the Offering. After the completion of the proposed Offering, Johnson & Johnson will no longer own any shares of Kenvue's common stock. Goldman Sachs & Co. LLC, J.P. Morgan and BofA Securities are acting as joint lead book-running managers for the Offering.

User Image DonCorleone77 Posted - 6 days ago

$KVUE Kenvue files to sell 182.33M shares of common stock for holders Goldman Sachs & Co., J.P. Morgan, BofA Securities are managing the offering.

User Image Stock_Titan Posted - 6 days ago

$KVUE $JNJ Kenvue Announces Launch of Secondary Offering https://www.stocktitan.net/news/KVUE/kenvue-announces-launch-of-secondary-dzz0h794erxm.html

User Image JakeMould Posted - 6 days ago

$KVUE Analyst price target for today. stock-thoughts.winning-trading-room.xyz

User Image LukeKibble Posted - 1 week ago

$kvue Analyst price target for next week. live-stock-trade-learning-support.winning-trading-room.xyz

User Image OptionRunners Posted - 1 week ago

$KVUE calls are ITM now up to $0.35

User Image OptionRunners Posted - 1 week ago

$KVUE early buyer of the May 17th $20.50 calls 4,000 times for $0.13. Already up to $0.25.

User Image TeresaTrades Posted - 1 week ago

Largest CALL OI decreases $KVUE $DIS $AAPL $NVDA $TSLA

User Image ApexSeidon Posted - 1 week ago

$KVUE 20P 6/21exp $239k .45 Avg

User Image sandman7473 Posted - 1 week ago

$KVUE this name paid well if you got in last week. Er crushed it.

User Image InvestorPlace Posted - 1 week ago

Kenvue Layoffs 2024: What to Know About the Latest $KVUE Job Cuts https://investorplace.com/2024/05/kenvue-layoffs-2024-what-to-know-about-the-latest-kvue-job-cuts/

User Image Ro_Patel Posted - 1 week ago

CFRA reiterates Buy rating on $KVUE & keeps TP of $23

User Image Doorkey Posted - 1 week ago

$KVUE $22 - $25 would be cool.

User Image stockpicker63 Posted - 1 week ago

Stocks to watch today! $HIMS, $KVUE and $ZETA .

User Image StagflationRecession Posted - 1 week ago

$KVUE Taking my $1.00 profit today.....better than $0.20 dividend immediately....Will buy back cheaper on ex- dividend day as MM's play it that day !!

User Image theflynews Posted - 1 week ago

Fly Intel: Pre-market Movers - $KVUE - https://thefly.com/permalinks/entry.php/KVUEid3912279

Analyst Ratings
HSBC Hold May 8, 24
Bernstein Underperform Apr 11, 24
William Blair Market Perform Apr 3, 24
Goldman Sachs Neutral Mar 4, 24
Goldman Sachs Neutral Mar 1, 24
RBC Capital Outperform Feb 13, 24
JP Morgan Overweight Feb 9, 24
RBC Capital Outperform Feb 9, 24
UBS Neutral Dec 19, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ALLISON RICHARD E JR Director Director Aug 30 Buy 22.9589 5,598 128,524 25,598 08/31/23